EGFR and non-small cell lung carcinoma: In NSCLC patients, EGFR gene mutation appeared more frequently in patients with the level of CYFRA 21-1 < 2.5 ng/mL (56.77% vs. 46.61%; p = 0.005), and EGFR mutation was correlated with CYFRA 21-1 level [9].